Weekly Pharma & Life Science News Round-Up: 15th – 19th August

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 15^th-19^th August 2022.

Medicines and Healthcare products Regulatory Agency (MHRA) authorizes Moderna’s Omicron-containing bivalent booster in the UK

Moderna, Inc. announces that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted conditional authorization of the use of the Omicron-containing bivalent COVID-19 booster vaccine, mRNA-1273.214.

IQVIA wins Snowflake’s “Marketplace Healthcare and Life Sciences Partner of the Year” award

IQVIA announces it has been named the 2022 Marketplace Healthcare and Life Sciences Partner of the Year by Snowflake, the Data Cloud company.

BeiGene announces strategic alliance with Ontada to improve U.S. community oncology care

BeiGene announces a strategic agreement with Ontada®, a McKesson business with leading provider technology and actionable real-world research, education, and evidence in oncology, to improve U.S. community oncology care through the development of real-world evidence (RWE) data, tools, and insights to help increase access to affordable, cutting-edge therapies.

BD, Accelerate Diagnostics announce global commercial collaboration

BD announces a worldwide commercial collaboration agreement where BD will offer Accelerate’s rapid testing solution for antibiotic resistance and susceptibility offering results in hours, versus one to two days with some traditional laboratory methods.

Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source

Gerresheimer AG and Zollner Elektronik AG are pooling their market-leading pharmaceutical and medical technology expertise under a strategic partnership.

New HEE programme launches to equip a generation of clinicians with generalist skills

A programme aiming to equip a new generation of healthcare professionals with generalist skills has been launched by Health Education England (HEE) – with 150 learners being enrolled across England.

TrakCel celebrates 10 years of market leading Cell Orchestration Solutions by setting out future plans

TrakCel, the leading supplier of cellular orchestration solutions for clinical trials and commercial therapies to the cell and gene therapy (CGT) industry, today is celebrating 10 years of supporting CGT developers, and shares its additional future plans to support the cell and gene therapy industry.

ProBioGen executes a Master Service Agreement with NextPoint Therapeutics and starts an integrated project from cell line development to GMP manufacturing

ProBioGen is delighted to close a Master Service Agreement with NextPoint and initiate development and GMP manufacturing of their lead antibody candidate.

Breakthrough Parkinson’s technology moves to next stage in NICE evaluation

More than 150,000 people with Parkinson’s Disease in the UK may soon benefit from public funding for new technology that physicians say could deliver a “paradigm shift” in Parkinson’s treatment.

Medartis reports 20% sales growth and makes further progress in strengthening its US organisation

Medartis Holding AG, an orthopaedic company specialising in head and extremity surgery, reported first half net sales growth of 20.1% (CER).